BioSpace News Archive

MDxHealth: Shareholder Transparency Declaration - Jan. 17, 2018

Capfi Delen Asset Management is a Belgian Management Company of UCITS. For further information, reference is made to the information published on MDxHealth’s website.

January 17, 2018
·
3 min read
Genetown

PathMaker Neurosystems Receives Award from Non-Profit Consortium to Support Development of MyoAmplifier for the Non-Invasive Treatment of Pediatric Paralysis and Muscle Weakness

The funding and in-kind services provided by the NEPDC will support development of PathMaker’s MyoAmplifier system, an advanced non-invasive platform that treats patients with paralysis and muscle weakness.

January 17, 2018
·
3 min read
Pharm Country

AzurRx BioPharma Receives $2M in Proceeds From Exercise of Warrants

The exercise transactions were negotiated with certain warrant holders as a means of raising additional working capital and were completed under the terms of warrant repricing agreements.

January 17, 2018
·
3 min read
Business

SOPHiA GENETICS Appoints Valentin Matillon as New CFO

Matillon brings over twenty years of experience in senior financial management positions in leading technology organizations, including SITA, Hewlett-Packard and Electronic Arts.

January 17, 2018
·
3 min read
BioMidwest

AveXis Announces Pricing of Public Offering of Common Stock - Jan. 17, 2018

The offering is expected to close on or about January 19, 2018, subject to customary closing conditions.

January 17, 2018
·
3 min read
Innovative Antibody Production: Helmholtz Association Funding Spin-Off

The Helmholtz Association is funding a new Helmholtz Zentrum München spin-off with roughly 115,000 euros.

January 17, 2018
·
5 min read
Ziath to Showcase New Low-Profile 2D Barcode Scanner for Liquid Handling Systems at SLAS2018

This innovative camera-based scanner has a low-profile design enabling it to be easily integrated with robotic liquid handling systems, as well as other laboratory automation solutions.

January 17, 2018
·
2 min read
Business

Celsee and IncellDx Sign Co-Commercialization Agreement Following Successful Lung Cancer/CTC PD-L1 Feasibility Study

The statistically-significant feasibility study analyzed PD-L1 expression in paired lung tumor biopsy and peripheral blood specimens using two different molecular analysis technologies, the IncellDx OncoTect iO Single Cell Quantitative PD-L1 assay and the Celsee C-Prep Genesis.

January 17, 2018
·
4 min read
Business

Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum

Baum is a highly respected biotech executive who has held leadership positions at numerous companies, from biotech startups to publicly-traded companies.

January 17, 2018
·
3 min read
Business

Biogennix Reports Record Growth for 2017; Expands Executive Management Team

The company closed the year with 47% growth, the broadest increase the company has experienced in its history.

January 17, 2018
·
3 min read